Centre intensifies regulatory surveillance over GLP-1 weight loss drugs
GS2राजव्यवस्था · शासन · अंतर्राष्ट्रीय संबंध· Health policy & public health· Prelims + Mains·
चर्चा में क्यों
The Drugs Controller of India intensified regulatory surveillance and issued a Health Ministry advisory to curb the unauthorized sale and promotion of GLP-1 weight loss drugs.
पृष्ठभूमि
The Health Ministry prohibited surrogate advertisements and indirect promotion of GLP-1 drugs. Audits and inspections were conducted at 49 entities across India to ensure these drugs are only used under prescription from specialists like endocrinologists and cardiologists.
प्रीलिम्स के लिए तथ्य
- संस्थाDrugs Controller of India: The primary regulatory body overseeing drug surveillance and safety.
- तथ्य49 entities across India were audited and inspected for unauthorized drug promotion.
- विज्ञान-तकनीकGLP-1 drugs: Medications approved for specific indications requiring prescriptions from endocrinologists, internal medicine specialists, or cardiologists.
मेन्स के लिए
Q. Discuss the challenges in regulating the pharmaceutical market in India, specifically regarding the unauthorized promotion of prescription-only drugs for lifestyle conditions.
उत्तर के आयाम
- Regulatory gap: Difficulty in monitoring surrogate advertising and indirect promotion of prescription-only medications.
- Public health risk: Potential for severe side effects due to self-medication without specialist supervision.
- Market oversight: Need for robust audit mechanisms to monitor pharmaceutical distribution chains.
कीवर्ड: Regulatory surveillance · Surrogate advertising · Patient safety · Prescription-only drugs · Pharmaceutical oversight
सामाजिक न्याय पर और नोट्स
- Odisha’s Late Marriage Incentives fails to reach beneficiaries in PVTGs, says CAG · 31 मार्च 2026
- On the implications of euthanasia in India · 31 मार्च 2026
- 1.22 lakh Anganwadi workers in Rajasthan get ₹1,000 each through DBT · 31 मार्च 2026
- Putting trans people under OBC quota gives no real benefit, says Rajasthan High Court · 30 मार्च 2026
- Transgender Amendment Bill gets President Murmu’s assent · 30 मार्च 2026
- STF hails Telangana government’s initiatives to improve learning outcomes and access to quality education · 29 मार्च 2026
कोई गलती या कोई कमी?
किसी नोट में गलती दिखे, या तैयारी के लिए कोई टॉपिक, फॉर्मेट या पीडीएफ चाहिए, तो हमें लिखें। हम हर मेल पढ़ते हैं और गलतियाँ जल्दी ठीक करते हैं।
यह नोट सत्यधीश के समाचार फ़ीड से स्वचालित रूप से तैयार किया गया है और यूपीएससी सीएसई पाठ्यक्रम से जुड़ा है। उत्तर में उपयोग करने से पहले तथ्यों का मूल रिपोर्ट या पीआईबी से मिलान करें।